NTRK1 and cancer: Studies have suggested that before cancer cells migrate to peripheral neurons, SCs migrate to pancreatic or colon cancer cells through the NGF-TrkA-p75NTR signaling pathway, but do not migrate to benign cells, so activated oncogenic SCs are likely to construct a pathway to cancer cells [84].